Sofosbuvir & Velpatasvir is another hepatitis C direct-acting antiviral drug from the American company Gilead under the brand name Epclusa as the backbone. Patients with chronic hepatitis c must first undergo a systemic examination before taking Epclusa. Epclusa has little side effects but a high cure rate. Sofosbuvir & Velpatasvir is used in combination with ribavirin, another antiviral drug, to treat advanced liver cirrhosis. If you are thinking to save on Sofosbuvir & Velpatasvir, then you should choose generic. Read more- https://www.medixocentre.com/sofosbuvir-and-velpatasvir